Get started
Author

Galal Mohsen Hussein Alsayadi

Observed names: Galal Mohsen Hussein Al-Sayadi, Galal Mohsen Hussein Al-sayadi
ORCID: 0000-0001-5490-584X
Observed ORCID: 0000-0001-5490-584X
OpenAlex ID: A5022799433
Solid Lipid Nanoparticles (SLNs): Advancements in Modification Strategies Toward Drug Delivery Vehicle
2022 · Galal Mohsen Hussein Al-Sayadi, Abhishek Verma, et al. · Pharmaceutical Nanotechnology · 32
Food Additives: Recent Advances and Development
2023 · Simranjeet Kaur, Simran Kaur, et al. · Current Nutrition & Food Science · 7
Development of QCT loaded TPGS coated solid lipid nanoparticles for improved in vivo neuroprotective activity in LPS administered adult zebrafish model: A QbD-based approach
2024 · Galal Mohsen Hussein Al-sayadi, Gurisha Garg, et al. · OpenNano · 5
Microwave-assisted processes and their applications
2022 · Abhishek Verma, Galal Mohsen Hussein Alsayadi, et al. · Pharmaspire · 3
PDF
Liposomal drug delivery: Recent developments and challenges
2022 · Pallavi Sandal, Galal Mohsen Hussein Alsayadi, et al. · Pharmaspire · 2
PDF
Recent advancements in nanoparticles drug delivery systems
2022 · Yash Choudhary, Abhishek Verma, et al. · Pharmaspire · 1
PDF
Lipid nanoparticles: An advanced delivery system for quercetin
2022 · Galal Mohsen Hussein Alsayadi, Junaid Ul Hamid, et al. · Pharmaspire · 1
PDF
The N-Nitrosamine Crisis in Antidiabetic Drugs: Toxicological Insights, Regulatory Challenges, Analytical Detection and Clinical Implications
2026 · Purnima Dhar, Yunes M.M.A. Alsayadi, et al. · Current Pharmaceutical Design
Works count: 8
Citation count: 51
H-index: 3
I10-index: 1
Year
Topic
Type